You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

STREPTOMYCIN SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Streptomycin Sulfate, and when can generic versions of Streptomycin Sulfate launch?

Streptomycin Sulfate is a drug marketed by Copanos, Lilly, Pfizer, and Xgen Pharms. and is included in six NDAs.

The generic ingredient in STREPTOMYCIN SULFATE is streptomycin sulfate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the streptomycin sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Streptomycin Sulfate

A generic version of STREPTOMYCIN SULFATE was approved as streptomycin sulfate by XGEN PHARMS on June 30th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for STREPTOMYCIN SULFATE?
  • What are the global sales for STREPTOMYCIN SULFATE?
  • What is Average Wholesale Price for STREPTOMYCIN SULFATE?
Drug patent expirations by year for STREPTOMYCIN SULFATE
Drug Prices for STREPTOMYCIN SULFATE

See drug prices for STREPTOMYCIN SULFATE

Recent Clinical Trials for STREPTOMYCIN SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Allergy and Infectious Diseases (NIAID)N/A

See all STREPTOMYCIN SULFATE clinical trials

Pharmacology for STREPTOMYCIN SULFATE
Medical Subject Heading (MeSH) Categories for STREPTOMYCIN SULFATE

US Patents and Regulatory Information for STREPTOMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Copanos STREPTOMYCIN SULFATE streptomycin sulfate INJECTABLE;INJECTION 060684-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer STREPTOMYCIN SULFATE streptomycin sulfate INJECTABLE;INJECTION 060076-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly STREPTOMYCIN SULFATE streptomycin sulfate INJECTABLE;INJECTION 060107-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xgen Pharms STREPTOMYCIN SULFATE streptomycin sulfate INJECTABLE;INJECTION 064210-001 Jun 30, 1998 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly STREPTOMYCIN SULFATE streptomycin sulfate INJECTABLE;INJECTION 060107-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly STREPTOMYCIN SULFATE streptomycin sulfate INJECTABLE;INJECTION 060404-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.